Role of anti-CD20 monoclonal antibody in association with immunomodulatory agents

Publisher： Elsevier

ISSN： 0369-8114

Source： Pathologie Biologie, Vol.52, Iss.1, 2004-01, pp. : 39-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab

By Pickartz T. Ringel F. Wedde M. Renz H. Klein A. von Neuhoff N. Dreger P. Kreuzer K.A. Schmidt C.A. Srock S. Schoeler D. Schriever F.

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1410-1416

Elsevier

Access to resources Recommend Favorite

Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

By Mourad Yasser Taher Ali Chehal Aref Shamseddine Ali

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 319-321

Springer Publishing Company

Access to resources Recommend Favorite

In vitro and in vivo effects of an anti-CD45 monoclonal antibody in the rat

By Ko S. Nakano H. Deiwick A. Dinkel A. Wonigeit K. Schlitt H.J.

Transplantation Proceedings, Vol. 31, Iss. 5, 1999-08 ,pp. : 1946-1947

Elsevier

Access to resources Recommend Favorite

Anti-CD45RB Monoclonal Antibody-Mediated Transplantation Tolerance

Current Molecular Medicine, Vol. 1, Iss. 5, 2001-11 ,pp. : 533-543

Bentham Science Publishers

Access to resources Recommend Favorite

Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)

By Gonzalez-Stawinski G.V. Yu P.B. Love S.D. Parker W. Davis R.D.

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 175-179

Academic Press

Access to resources Recommend Favorite